← European Medicine Shortage Tracker · all medicines

Argatrobanmonohydrat shortage — availability across Europe

Argatrobanmonohydrat currently has availability issues reported in 1 European register: Sweden.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Expected shortage  ATC — · also listed as: argatrobanmonohydrat · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Argatrobanmonohydrat, covering 1 affected product presentation. The furthest expected-resolution date currently on file is 2026-10-31; the earliest is 2026-10-31. Registers in Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇸🇪 SwedenExpected shortage
Novastan 100 mg/ml Koncentrat till infusionsvätska, lösning
2026-08-312026-10-31
Alternatives: Alternative(s) available — see the national register.
register ↗

Full report history (1 register entry)

Every individual register entry for Argatrobanmonohydrat in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇸🇪 SENovastan 100 mg/ml Koncentrat till infusionsvätska, lösningExpected shortage2026-08-312026-10-31

Frequently asked

Is Argatrobanmonohydrat currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Argatrobanmonohydrat shortage expected to end?

Agency prognoses on file range from 2026-10-31 to 2026-10-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Argatrobanmonohydrat?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Argatrobanmonohydrat availability data come from?

Directly from the official medicines-agency register that lists Argatrobanmonohydrat: Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Argatrobanmonohydrat — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/argatrobanmonohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Argatrobanmonohydrat availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/argatrobanmonohydrat/">Argatrobanmonohydrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Argatrobanmonohydrat: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.